Skip to main content
SpringerLink
Log in

Ein Leitfaden für die Praxis

Akne vulgaris: Das können Sie für Betroffene tun

Acne in medical practices: Therapy and diagnostic

  • FORTBILDUNG . ÜBERSICHT
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Zusammenfassung

Die Akne vulgaris ist eine harmlose, chronisch entzündliche Erkrankung der Haartalgdrüsen. Sie beginnt meist in der 2. Lebensdekade und gehört zu den häufigsten dermatologischen Erkrankungen. Betroffene haben oft einen enormen Leidensdruck. Lesen Sie hier, wie Sie Ihren Patienten Linderung verschaffen können.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol. 2013;168:474–5.

    Article  CAS  PubMed  Google Scholar 

  2. Wolkenstein P, Machovcova A, Szepietowski JC, Tennstedt D, Veraldi S, Delarue A. Acne prevalence and associations with lifestyle: a cross-sectional online survey of adolescents/young adults in 7 European countries. J Eur Acad Dermatol Venereol. 2018;32:298–306.

    Article  CAS  PubMed  Google Scholar 

  3. Latter G, Grice JE, Mohammed Y, Roberts MS, Benson HAE. Targeted Topical Delivery of Retinoids in the Management of Acne Vulgaris: Current Formulations and Novel Delivery Systems. Pharmaceutics 2019;11.

  4. Poli F, Dreno B, Verschoore M. An epidemiological study of acne in female adults: results of a survey conducted in France. J Eur Acad Dermatol Venereol 2001;15:541–5.

    Article  CAS  PubMed  Google Scholar 

  5. Ghodsi SZ, Orawa H, Zouboulis CC. Prevalence, severity, and severity risk factors of acne in high school pupils: a communitybased study. J Invest Dermatol. 2009;129:2136–41

    Article  CAS  PubMed  Google Scholar 

  6. Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, Shalita AR, Thiboutot D. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49:S1–37.

    Article  PubMed  Google Scholar 

  7. Hazarika N. Acne vulgaris: new evidence in pathogenesis and future modalities of treatment. J Dermatolog Treat. 2019:1–33.

    Google Scholar 

  8. Cong TX, Hao D, Wen X, Li XH, He G, Jiang X. From pathogenesis of acne vulgaris to antiacne agents. Arch Dermatol Res. 2019;311:337–9.

    Article  PubMed  Google Scholar 

  9. Moradi Tuchayi S, Makrantonaki E, Ganceviciene R, Dessinioti C, Feldman SR, Zouboulis CC. Acne vulgaris. Nat Rev Dis Primers. 2015;1:15029.

    Article  Google Scholar 

  10. Anzengruber F, Ruhwinkel K, Ghosh A, Klaghofer R, Lang UE, Navarini AA. Wide range of age of onset and low referral rates to psychiatry in a large cohort of acne excoriee at a Swiss tertiary hospital. J Dermatolog Treat. 2018;29:277–80.

    Article  PubMed  Google Scholar 

  11. Kazandjieva J, Tsankov N. Drug-induced acne. Clin Dermatol 2017;35:156–62.

    Article  PubMed  Google Scholar 

  12. Back O, Faergemann J, Hornqvist R. Pityrosporum folliculitis: a common disease of the young and middle-aged. J Am Acad Dermatol. 1985;12:56–61.

    Article  CAS  PubMed  Google Scholar 

  13. Hsu CK, Hsu MM, Lee JY. Demodicosis: a clinicopathological study. J Am Acad Dermatol. 2009;60:453–62.

    Article  PubMed  Google Scholar 

  14. Levy A, Feuilhade de Chauvin M, Dubertret L, Morel P, Flageul B. [Malassezia folliculitis: characteristics and therapeutic response in 26 patients]. Ann Dermatol Venereol. 2007;134:823–8.

    Article  CAS  PubMed  Google Scholar 

  15. Chen WC, Zouboulis CC. Hormones and the pilosebaceous unit. Dermatoendocrinol. 2009;1:81–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Zouboulis CC, Degitz K. Androgen action on human skin — from basic research to clinical significance. Exp Dermatol. 2004;13(Suppl 4):5–10.

    Article  CAS  PubMed  Google Scholar 

  17. Oge LK, Broussard A, Marshall MD. Acne Vulgaris: Diagnosis and Treatment. Am Fam Physician. 2019;100:475–84.

    PubMed  Google Scholar 

  18. Smith K. Mental health: a world of depression. Nature. 2014;515:181.

    PubMed  Google Scholar 

  19. Alirezai M, George SA, Coutts I, Roseeuw DI, Hachem JP, Kerrouche N, Sidou F, Soto P. Daily treatment with adapalene gel 0.1% maintains initial improvement of acne vulgaris previously treated with oral lymecycline. Eur J Dermatol. 2007;17:45–51.

    CAS  PubMed  Google Scholar 

  20. Adler BL, Kornmehl H, Armstrong AW. Antibiotic Resistance in Acne Treatment. JAMA Dermatol. 2017;153:810–1.

    Article  PubMed  Google Scholar 

  21. Coates P, Vyakrnam S, Eady EA, Jones CE, Cove JH, Cunliffe WJ. Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. Br J Dermatol. 2002;146:840–8.

    Article  CAS  PubMed  Google Scholar 

  22. Eady AE, Cove JH, Layton AM. Is antibiotic resistance in cutaneous propionibacteria clinically relevant?: implications of resistance for acne patients and prescribers. Am J Clin Dermatol. 2003;4:813–31.

    Article  PubMed  Google Scholar 

  23. Fluhr JW, Gloor M, Dietz P, Hoffler U. In Vitro activity of 6 antimicrobials against propionibacteria isolates from untreated acne papulopustulosa. Zentralbl Bakteriol 1999;289:53–61.

    Article  CAS  PubMed  Google Scholar 

  24. Ross JI, Eady EA, Cove JH, Ratyal AH, Cunliffe WJ. Resistance to erythromycin and clindamycin in cutaneous propionibacteria is associated with mutations in 23S rRNA. Dermatology. 1998;196:69–70.

    Article  CAS  PubMed  Google Scholar 

  25. Loureiro KD, Kao KK, Jones KL, Alvarado S, Chavez C, Dick L, Felix R, Johnson D, Chambers CD. Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy. Am J Med Genet A. 2005;136:117–21.

    Article  PubMed  Google Scholar 

  26. Brand B, Gilbert R, Baker MD, Poncet M, Greenspan A, Georgeian K, Soto P. Cumulative irritancy potential of adapalene cream 0.1% compared with adapalene gel 0.1% and several tretinoin formulations. Cutis. 2003;72:455–8.

    PubMed  Google Scholar 

  27. Galvin SA, Gilbert R, Baker M, Guibal F, Tuley MR. Comparative tolerance of adapalene 0.1% gel and six different tretinoin formulations. Br J Dermatol. 1998;139(Suppl 52):34–40.

    Article  CAS  PubMed  Google Scholar 

  28. Alexis AF, Cook-Bolden FE, York JP. Adapalene/Benzoyl Peroxide Gel 0.3%/2.5%: A Safe and Effective Acne Therapy in All Skin Phototypes. J Drugs Dermatol. 2017;16:574–81.

    CAS  PubMed  Google Scholar 

  29. Kawashima M, Nagare T, Katsuramaki T. Open-label, randomized, multicenter, phase III study to evaluate the safety and efficacy of benzoyl peroxide gel in long-term use in patients with acne vulgaris: A secondary publication. J Dermatol. 2017;44:635–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Leyden JJ, Berger RS, Dunlap FE, Ellis CN, Connolly MA, Levy SF. Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with benzoyl peroxide, clindamycin and vehicle gel in the treatments of acne vulgaris. Am J Clin Dermatol. 2001;2:33–9.

    Article  CAS  PubMed  Google Scholar 

  31. Thiele JJ. Oxidative targets in the stratum corneum. A new basis for antioxidative strategies. Skin Pharmacol Appl Skin Physiol. 2001;14(Suppl 1):87–91.

    Article  CAS  PubMed  Google Scholar 

  32. Cunliffe WJ, Burke B. Benzoyl peroxide: lack of sensitization. Acta Derm Venereol. 1982;62:458–9.

    CAS  PubMed  Google Scholar 

  33. Kainz JT, Berghammer G, Auer-Grumbach P, Lackner V, Perl-Convalexius S, Popa R, Wolfesberger B. Azelainsaure 20 % Creme: Auswirkung auf Lebensqualitat und Krankheitsaktivitat bei erwachsenen Patientinnen mit Acne vulgaris. J Dtsch Dermatol Ges. 2016;14:1249–60.

    PubMed  Google Scholar 

  34. Cunliffe WJ. Evolution of a strategy for the treatment of acne. J Am Acad Dermatol. 1987;16:591–9.

    Article  CAS  PubMed  Google Scholar 

  35. Gollnick HP, Graupe K, Zaumseil RP. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne. Eur J Dermatol. 2001;11:538–44.

    CAS  PubMed  Google Scholar 

  36. Greenwood R, Brummitt L, Burke B, Cunliffe WJ. Acne: double blind clinical and laboratory trial of tetracycline, oestrogen-cyproterone acetate, and combined treatment. Br Med J. (Clin Res Ed.) 1985;291:1231–5.

    Article  CAS  Google Scholar 

  37. Mills OH, Jr., Marples RR, Kligman AM. Acne vulgaris. Oral therapy with tetracycline and topical therapy with vitamin A. Arch Dermatol.1972;106:200–3.

    Article  PubMed  Google Scholar 

  38. Hauk L. Acne Vulgaris: Treatment Guidelines from the AAD. Am Fam Physician. 2017;95:740–1.

    PubMed  Google Scholar 

  39. Ganceviciene R, Zouboulis CC. Isotretinoin: state of the art treatment for acne vulgaris. J Dtsch Dermatol Ges. 2010;8(Suppl 1):S47–59.

    Article  PubMed  Google Scholar 

  40. Orfanos CE, Zouboulis CC. Oral retinoids in the treatment of seborrhoea and acne. Dermatology. 1998;196:140–7.

    Article  CAS  PubMed  Google Scholar 

  41. Arowojolu AO, Gallo MF, Lopez LM, Grimes DA. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev. 2012:Cd004425.

    Google Scholar 

  42. van Vloten WA, Sigurdsson V. Selecting an oral contraceptive agent for the treatment of acne in women. Am J Clin Dermatol. 2004;5:435–41.

    Article  PubMed  Google Scholar 

  43. Scherdin U, Presto S, Rippke F, Nielsen J, Strassner M, Imadojemun A, Gartner E, Herpens A, Korting HC, Bielfeldt S. In vivo assessment of the efficacy of an innovative face care system in subjects with mild acne vulgaris. Int J Cosmet Sci. 2004;26:221–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Dermatologie, Universitätsklinikum Düsseldorf, Moorenstraße 5, D-40225, Düsseldorf, Deutschland

    Ulrich P. Wehry &  Norman-Philipp Hoff

Authors
  1. Ulrich P. Wehry
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Norman-Philipp Hoff
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ulrich P. Wehry.

Additional information

Interessenkonflikt

Die Autoren erklären, dass sie sich bei der Erstellung des Beitrages von keinen wirtschaftlichen Interessen leiten ließen. Sie legen folgende potenzielle Interessenkonflikte offen: keine.

Der Verlag erklärt, dass die inhaltliche Qualität des Beitrags von zwei unabhängigen Gutachtern geprüft wurde. Werbung in dieser Zeitschriftenausgabe hat keinen Bezug zur CME-Fortbildung. Der Verlag garantiert, dass die CME-Fortbildung sowie die CME-Fragen frei sind von werblichen Aussagen und keinerlei Produktempfehlungen enthalten. Dies gilt insbesondere für Präparate, die zur Therapie des dargestellten Krankheitsbildes geeignet sind.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wehry, U.P., Hoff, NP. Akne vulgaris: Das können Sie für Betroffene tun. MMW - Fortschritte der Medizin 162, 54–62 (2020). https://doi.org/10.1007/s15006-020-0003-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-020-0003-0

Keywords

Search

Navigation